- Home
- AVR vs FSP Comparison
AVR vs FSP Comparison
Compare AVR & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVR
- FSP
- Stock Information
- Founded
- AVR 1999
- FSP 1981
- Country
- AVR Australia
- FSP United States
- Employees
- AVR N/A
- FSP N/A
- Industry
- AVR
- FSP Real Estate Investment Trusts
- Sector
- AVR
- FSP Real Estate
- Exchange
- AVR NYSE
- FSP Nasdaq
- Market Cap
- AVR 215.6M
- FSP 187.5M
- IPO Year
- AVR 2024
- FSP N/A
- Fundamental
- Price
- AVR $5.99
- FSP $1.86
- Analyst Decision
- AVR Strong Buy
- FSP
- Analyst Count
- AVR 4
- FSP 0
- Target Price
- AVR $16.50
- FSP N/A
- AVG Volume (30 Days)
- AVR 158.4K
- FSP 310.2K
- Earning Date
- AVR 01-01-0001
- FSP 02-24-2025
- Dividend Yield
- AVR N/A
- FSP 2.15%
- EPS Growth
- AVR N/A
- FSP N/A
- EPS
- AVR N/A
- FSP N/A
- Revenue
- AVR $2,826,588.00
- FSP $126,508,000.00
- Revenue This Year
- AVR N/A
- FSP N/A
- Revenue Next Year
- AVR N/A
- FSP $0.02
- P/E Ratio
- AVR N/A
- FSP N/A
- Revenue Growth
- AVR N/A
- FSP N/A
- 52 Week Low
- AVR $5.10
- FSP $1.47
- 52 Week High
- AVR $6.10
- FSP $2.58
- Technical
- Relative Strength Index (RSI)
- AVR N/A
- FSP 51.16
- Support Level
- AVR N/A
- FSP $1.69
- Resistance Level
- AVR N/A
- FSP $1.90
- Average True Range (ATR)
- AVR 0.00
- FSP 0.06
- MACD
- AVR 0.00
- FSP 0.00
- Stochastic Oscillator
- AVR 0.00
- FSP 77.27
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The company's operations include rental income from real estate leasing, interest income from secured loans made on office properties, property dispositions, and fee income from asset/property management and development. Franklin Street markets Atlanta, Dallas, Denver, Houston, and Minneapolis.